1627. Tedizolid is Well-tolerated Among Patients Receiving Prolonged Treatment Courses, Including Those Who are Intolerant of Alternative Agents

BACKGROUND: Tedizolid (TZD) is approved for acute bacterial skin and skin structure infections (ABSSSI), but often used for complicated infections to avoid linezolid (LZD) adverse events (AE), particularly when long-term treatment is indicated. This studied aimed to characterize the tolerability of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Smith, Brandon, Marini, Rachel V, Spigelmyer, Amy, Clarke, Lloyd, Shields, Ryan K
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Poster Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778098/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1807
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker